Trump's New Tariff Plan: A Renewed Focus on Pharmaceuticals and Metals

President Donald Trump has introduced new tariffs on pharmaceutical imports and revised duties on metals to support U.S. industries and reduce costs triggered by global tensions. These changes follow the collapse of previous tariffs struck down by the Supreme Court and aim to strengthen domestic production.

On Thursday, President Donald Trump announced a series of new tariffs on pharmaceutical imports and has revised duties on metals, aiming to revitalize domestic industries. This move comes in light of the collapse of last year's global tariffs which were struck down by the Supreme Court in February.

The revised policies prioritize large foreign pharmaceutical companies that now must agree to a U.S. government deal to cut drug prices and move production stateside in order to avoid new tariffs. These measures come amid increased energy prices due to tensions with Iran.

In the metals sector, Trump announced a reduction of duty rates from 50% to 25% on numerous steel, aluminum, and copper derivative products, intending to simplify the existing tariff system and support American industries. The new regulations will take effect on Monday, sparking mixed reactions from industry leaders.

(With inputs from agencies.)